TITLE

Basal cell carcinoma of the head and neck: Identification of predictors of recurrence

AUTHOR(S)
Bumpous, Jeffrey M.; Padhya, Tapan A.; Barnett, Susan N.
PUB. DATE
March 2000
SOURCE
ENT: Ear, Nose & Throat Journal;Mar2000, Vol. 79 Issue 3, p200
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The goal of this retrospective study was to identify factors that predict the recurrence of basal cell carcinoma of the head and neck. We reviewed the medical records of 165 patients who had undergone a wide surgical excision (negative margins) of one or more basal cell carcinomas of the head and neck. Univariate analysis revealed that recurrence was significantly influenced by the patient's gender (p<0.01), the presence of preoperative risk factors (p<0.05), the presence of multiple lesions (p<0.01), and their histopathologic subtype (p<0.05). Multivariate analysis revealed that the best predictors of recurrence were the presence of preoperative risk factors and the presence of multiple lesions (p<0.01); the lesion's histologic subtype approached but did not reach statistical significance in predicting recurrence (p=0.06).
ACCESSION #
2931833

 

Related Articles

  • The Sun and Your Skin. Goldstein, Glenn D.; Carroll, Patricia A. // Flower & Garden;Aug99, Vol. 43 Issue 4, p16 

    Provides information on skin cancer. Individuals who are at the highest risk for all types of skin cancer; Description on the appearance of skin cancer; Ways to prevent skin cancer. INSET: The Cosmetics Effects of Sun Exposure.

  • Your scariest skin-cancer questions--answered. Colino, Stacey; Kusek, Kristyn; Marrone, Stefanie // Redbook;Dec2001, Vol. 197 Issue 6, p30 

    Addresses questions about skin cancer.

  • Non-Melanoma Skin Cancers. Brown, Edwin // Medical Update;Dec98, Vol. 22 Issue 6, p4 

    Provides information on non-melanoma skin cancers. Spectrum of skin cancers; Relationship between the initial diagnosis of non-melanoma skin cancers and subsequent death from other cancers; Types of cancers that have increase risk.

  • Basal Cell Carcinoma: Treatment Options and Prognosis, a Scientific Approach to a Common Malignancy. Kuijpers, D.I.; Thissen, M.R.; Neumann, M.H. // American Journal of Clinical Dermatology;2002, Vol. 3 Issue 4, p247 

    The incidence of basal cell carcinoma is rapidly increasing and a number of treatment modalities are available. Treatment of basal cell carcinoma includes both surgical and nonsurgical approaches, some of which are traditional, and others experimental. The treatment modality utilized is...

  • Expression of individual lamins in basal cell carcinomas of the skin. Venables, R S; McLean, S; Luny, D; Moteleb, E; Morley, S; Quinlan, R A; Lane, E B; Hutchison, C J // British Journal of Cancer;2/15/2001, Vol. 84 Issue 4, p512 

    In this study we used a unique collection of type specific anti-lamin antibodies to study lamin expression patterns in normal human skin and in skin derived from patients with basal cell carcinomas (BCCs). Lamin expression in serial sections from frozen tissue samples was investigated by single...

  • Just a Scar? Elmer, Kathleen B.; George, Rita M. // American Family Physician;4/1/2000, Vol. 61 Issue 7, p2175 

    Presents a photograph of a patient with basal cell carcinoma. Description of the scar; Cause of basal cell carcinoma; Clinical varieties of basal cell carcinoma.

  • basal cell carcinoma:. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p36 

    The article presents an encyclopedia entry for basal cell carcinoma, a tumor of the skin that rarely metastasizes and manifests as a small, shiny papule.

  • SKIN-CANCER PREVENTIVE. Zarrow, Susan // Prevention;Feb90, Vol. 42 Issue 2, p19 

    Cites the result of a study pertaining to the potential of vitamin A in preventing skin cancer. Efficacy of low-level of isotretinoin in the treatment of basal cell skin cancer; Implications for chemoprevention.

  • Imiquimod tested as nonsurgical option. Guttman, Cheryl // Dermatology Times;Jul2001, Vol. 22 Issue 7, p16 

    Reports that the Aldara imiquimod five percent cream continues to demonstrate promise as an effective and well tolerated topical therapy for the treatment of primary, superficial basal cell carcinoma (BCC). Proof that imiquimod is a viable nonsurgical modality to successfully treating...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics